Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, Nanni C, Bianchi P, Cistaro A, Sorrentino S, Cabria M, Pession A, Puntoni M, Villavecchia G, Fanti S.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):57-71. doi: 10.1007/s00259-011-1938-2. Epub 2011 Sep 20.

PMID:
21932116
2.

Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.

Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.

Nucl Med Commun. 2011 Jul;32(7):575-82. doi: 10.1097/MNM.0b013e328345a340.

PMID:
21471850
3.

18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR.

Lopci E, Piccardo A, Nanni C, Altrinetti V, Garaventa A, Pession A, Cistaro A, Chiti A, Villavecchia G, Fanti S.

Clin Nucl Med. 2012 Apr;37(4):e73-8. doi: 10.1097/RLU.0b013e3182485172.

PMID:
22391727
4.

Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1046-56. doi: 10.1007/s00259-014-2691-0. Epub 2014 Feb 22.

PMID:
24562643
5.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.

Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Review.

6.

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.

Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):865-73. doi: 10.1007/s00259-010-1720-x. Epub 2011 Jan 29.

PMID:
21279352
7.

¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1648-58. doi: 10.1007/s00259-011-1843-8. Epub 2011 May 27.

PMID:
21617976
8.

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.

J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054. Epub 2009 Jul 21.

PMID:
19622618
9.

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K.

J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248. Epub 2009 Oct 28.

10.

Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.

Dhull VS, Sharma P, Patel C, Kundu P, Agarwala S, Bakhshi S, Bhatnagar V, Bal C, Kumar R.

Nucl Med Commun. 2015 Oct;36(10):1007-13. doi: 10.1097/MNM.0000000000000347.

PMID:
26049371
11.

Characterization of neuroblastic tumors using 18F-FDOPA PET.

Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, Lin DT, Lee YL, Lee H, Wu PY, Luo TY, Shen LH, Huang SF, Liao YF, Hsu WM, Tzen KY; National Taiwan University Neuroblastoma Study Group.

J Nucl Med. 2013 Jan;54(1):42-9. doi: 10.2967/jnumed.112.102772. Epub 2012 Dec 4.

12.

123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.

Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL.

J Nucl Med. 2009 Aug;50(8):1237-43. doi: 10.2967/jnumed.108.060467. Epub 2009 Jul 17.

13.

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A.

J Nucl Med. 2010 May;51(5):704-12. doi: 10.2967/jnumed.109.069765. Epub 2010 Apr 15.

14.

Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.

Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, Rufini V, Giordano A.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1144-53. doi: 10.1007/s00259-012-2087-y. Epub 2012 Feb 23. Review.

PMID:
22358431
15.

PET/CT imaging in neuroblastoma.

Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.

Q J Nucl Med Mol Imaging. 2013 Mar;57(1):29-39. Review.

PMID:
23474633
16.

Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.

Piccardo A, Lopci E, Conte M, Cabria M, Cistaro A, Garaventa A, Villavecchia G.

Clin Nucl Med. 2014 Jan;39(1):e80-3. doi: 10.1097/RLU.0b013e31827a0002.

PMID:
23579975
18.

Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.

Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, Glatting G, Buck AK, Solbach C, Neumaier B, Reske SN, Mottaghy FM.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):484-93. doi: 10.1007/s00259-009-1294-7. Epub 2009 Oct 28.

PMID:
19862519
19.

PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.

Yakemchuk VN, Jager PL, Chirakal R, Reid R, Major P, Gulenchyn KY.

Nucl Med Commun. 2012 Mar;33(3):322-30. doi: 10.1097/MNM.0b013e32834f2603.

PMID:
22183015
20.

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG.

J Clin Oncol. 2008 Mar 20;26(9):1489-95. doi: 10.1200/JCO.2007.15.1126.

Items per page

Supplemental Content

Write to the Help Desk